Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Introduction

The concept of occult breast carcinoma (OBC) was first described in 1907 by Halsted, who described this type of breast cancer to arise from small, undetectable tumours in the breast that had already metastasized to the lymph nodes. Although the breast is the most likely site for the primary tumour, non-palpable breast cancer presenting as an axillary metastasis has been reported, but with a low frequency of less than 0.5% of all breast cancers. OBC represents a complex diagnostic and therapeutic dilemma. Considering its rarity, clinicopathological information is still limited.

Case Report

A 44-year-old patient presented to the emergency room with an extensive axillary mass as the first manifestation. Conventional evaluation of the breast with mammography and ultrasound was unremarkable. However, a breast MRI confirmed the presence of conglomerate axillary nodes. A supplementary whole-body PET-CT established the axillary conglomerate with a malignant behaviour with SUV of 19.3. The primary tumour was not detected in the breast tissue of the patient, confirming the diagnosis of OBC. Immunohistochemical results showed positive receptors for estrogen and progesterone.

Conclusion

Although OBC is a rare diagnosis, its existence is a possibility in a patient with breast cancer. Mammography and breast ultrasound with unremarkable findings but with high clinical suspicion should be supplemented with additional imaging methods, such as MRI and PET-CT, emphasizing the appropriate pre-treatment evaluation.

© 2024 The Author(s). Published by Bentham Open. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405620666230515090511
2024-01-01
2024-11-23
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIM-20-e150523216891.html?itemId=/content/journals/cmir/10.2174/1573405620666230515090511&mimeType=html&fmt=ahah

References

  1. ŁukasiewiczS. CzeczelewskiM. FormaA. BajJ. SitarzR. StanisławekA. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review.Cancers20211317428710.3390/cancers1317428734503097
    [Google Scholar]
  2. TossA. MoscettiL. CascinuS. Occult breast cancer: The uncommon presentation of a common disease.Chin. Clin. Oncol.20198S1S1010.21037/cco.2019.01.0630823842
    [Google Scholar]
  3. ZhaoZ. ZhangT. YaoY. LuX. Clinicopathological characteristics and treatment outcomes of occult breast cancer: A population-based study.BMC Surg.202222114310.1186/s12893‑022‑01472‑835430796
    [Google Scholar]
  4. SaccarelliC.R. BitencourtA.G.V. MorrisE.A. Breast cancer screening in high-risk women: Is mri alone enough?J. Natl. Cancer Inst.2020112212112210.1093/jnci/djz13031233125
    [Google Scholar]
  5. AkhtarK. SinghS. SiddiquiS. AhmadS. FNAB of metastatic lesions with special reference to clinicopathological analysis of primary site in cases of epithelial and non-epithelial tumors.J. Cytol.2011282616510.4103/0970‑9371.8074021713149
    [Google Scholar]
  6. OfriA. MooreK. Occult breast cancer: Where are we at?Breast20205421121510.1016/j.breast.2020.10.01233130487
    [Google Scholar]
  7. CostantiniM. MontellaR.A. FaddaM.P. GarganeseG. Di LeoneA. SanchezA.M. FranceschiniG. RinaldiP.M. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): Role of contrast-enhanced spectral mammography (CESM) in detecting occult breast cancer.J. Pers. Med.202111646510.3390/jpm1106046534070278
    [Google Scholar]
  8. HalstedW.S. I. The results of radical operations for the cure of carcinoma of the breast.Ann. Surg.190746111910.1097/00000658‑190707000‑0000117861990
    [Google Scholar]
  9. HüppeJ.R. [The way to the detection of occult breast carcinoma. An appeal to radiologists, surgeons and pathologists for team-work].Radiologe197313114774814779089
    [Google Scholar]
  10. PatchefskyA.S. PotokJ. HochW.S. LibshitzH.I. Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies.Am. J. Clin. Pathol.197360679980410.1093/ajcp/60.6.7994357121
    [Google Scholar]
  11. ClarijsW.W. van Deelen-WillemsM. HendriksJ.H. LubbersE.J. SchmidtW.J. [The occult breast carcinoma].Ned. Tijdschr. Geneeskd.197712113526529846589
    [Google Scholar]
  12. SnydermanR.K. LizardoJ.G. Statistical study of malignancies found before, during, or after routine breast plastic operations.Plast. Reconstr. Surg.196025325325610.1097/00006534‑196003000‑0000613832341
    [Google Scholar]
  13. PitanguyI. TorresE.T. Histopathological aspects of mammary gland tissue in cases of plastic surgery of breast.Br. J. Plast. Surg.19641729730210.1016/S0007‑1226(64)80046‑114191134
    [Google Scholar]
  14. BaskotaSU QaziD ChandraA VohraP Comprehensive review of metastatic breast carcinoma in cytology specimens.J. Mol. Pathol.20223429330610.3390/jmp3040025
    [Google Scholar]
  15. WalkerG.V. SmithG.L. PerkinsG.H. OhJ.L. WoodwardW. YuT.K. HuntK.K. HoffmanK. StromE.A. BuchholzT.A. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.Cancer2010116174000400610.1002/cncr.2519720564117
    [Google Scholar]
  16. PavlidisN. PentheroudakisG. Cancer of unknown primary site.Lancet201237998241428143510.1016/S0140‑6736(11)61178‑122414598
    [Google Scholar]
  17. Sanuki-FujimotoN. TakedaA. AmemiyaA. OfuchiT. OnoM. YamagamiR. HatayamaJ. KuniedaE. ShigematsuN. Pattern of tumor recurrence in initially nonmetastatic breast cancer patients.Cancer2008113467768210.1002/cncr.2361218613072
    [Google Scholar]
  18. ZhangD. ZhaiJ. LiL. WuY. MaF. XuB. Prognostic factors and a model for occult breast cancer: A population-based cohort study.J. Clin. Med.20221122680410.3390/jcm1122680436431280
    [Google Scholar]
  19. Di MiccoR. SanturroL. GasparriM.L. ZuberV. FiaccoE. GazzettaG. SmartC.E. ValentiniA. GentiliniO.D. Rare sites of breast cancer metastasis: A review.Transl. Cancer Res.20198S5S518S55210.21037/tcr.2019.07.2435117130
    [Google Scholar]
  20. CamarneiroR. FerreiraÁ. BarrosM. Brito e MeloM. Occult breast cancer presenting as axillary lymphadenopathy – Case Report.Int. J. Surg. Case Rep.20229910767710.1016/j.ijscr.2022.10767736162357
    [Google Scholar]
  21. ZhangY. WuD. ZhaoB. TianX.L. YaoT.C. LiF. LiuW.F. ShiA.P. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature.World J. Clin. Cases20219491992610.12998/wjcc.v9.i4.91933585640
    [Google Scholar]
  22. KikumoriK. OshimaK. YanagawaT. EgawaC. TakatsukaY. ShinkeG. KatsuyamaS. KawaiK. HirakiM. KatsuraY. OhmuraY. MasuzawaT. HataT. TakedaY. MurataK. [Occult breast cancer presenting with a swelling axillary lymph node-a case report].Gan To Kagaku Ryoho202148131849185135045425
    [Google Scholar]
  23. FrattaroliF.M. CarraraA. ConteA.M. PappalardoG. Axillary metastasis as first symptom of occult breast cancer: A case report.Tumori200288653253410.1177/03008916020880062012597153
    [Google Scholar]
  24. TamiolakisD. AntoniouC. Axillary nodal metastasis of occult breast primary cancer.Chirurgia2008103446747118780622
    [Google Scholar]
  25. MonibS. PakdemirliE. ChongK. Mammographically and MRI occult breast cancer.BMJ Case Rep.2019126e23019010.1136/bcr‑2019‑23019031253664
    [Google Scholar]
  26. VomáčkováK. ZlámalováN. VeverkováL. SpáčilováK. DonocikováB. KolečkováM. Occult breast cancer: A case report and current management of treatment.Rozhl. Chir.2022101313814235387471
    [Google Scholar]
  27. WangX. ZhaoY. CaoX. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.Breast J.2010161323710.1111/j.1524‑4741.2009.00848.x20465598
    [Google Scholar]
  28. MannR.M. ChoN. MoyL. Breast MRI: State of the Art.Radiology2019292352053610.1148/radiol.201918294731361209
    [Google Scholar]
  29. MainieroM.B. MoyL. BaronP. DidwaniaA.D. diFlorioR.M. GreenE.D. HellerS.L. HolbrookA.I. LeeS.J. LewinA.A. LourencoA.P. NanceK.J. NiellB.L. SlanetzP.J. StuckeyA.R. VincoffN.S. WeinsteinS.P. YepesM.M. NewellM.S. ACR appropriateness criteria ® breast cancer screening.J. Am. Coll. Radiol.20171411S383S39010.1016/j.jacr.2017.08.04429101979
    [Google Scholar]
  30. ShawkyM. AliZ.A.E. HashemD.H. HouseniM. Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer.Egypt. J. Radiol. Nucl. Med.202051112510.1186/s43055‑020‑00244‑9
    [Google Scholar]
  31. HomeshN.A. IssaM.A. El-SofianiH.A. The diagnostic accuracy of fine needle aspiration cytology versus core needle biopsy for palpable breast lump(s).Saudi Med. J.2005261424615756351
    [Google Scholar]
  32. KittanehM. MonteroA.J. GlückS. Molecular profiling for breast cancer: A comprehensive review.Biomark. Cancer20135BIC.S945510.4137/BIC.S945524250234
    [Google Scholar]
  33. de AndradeJ.M. MaranaH.R.C. FilhoJ.M.S. MurtaE.F.C. VelludoM.A.S.L. BighettiS. Differential diagnosis of axillary masses.Tumori199682659659910.1177/0300891696082006179061072
    [Google Scholar]
  34. DialaniV. JamesD.F. SlanetzP.J. A practical approach to imaging the axilla.Insights Imaging20156221722910.1007/s13244‑014‑0367‑825534139
    [Google Scholar]
  35. YamaguchiH. IshikawaM. HatanakaK. UekusaT. IshimaruM. NagawaH. Occult breast cancer presenting as axillary metastases.Breast200615225926210.1016/j.breast.2005.04.01815996865
    [Google Scholar]
  36. AltanE. AltundagK. Clinical and pathological characteristics of occult breast cancer and review of the literature.J. BUON201116343443622006745
    [Google Scholar]
  37. LuS. LiuH. [Diagnosis and treatment of occult breast cancer in 44 cases].Zhonghua Zhong Liu Za Zhi201133755055222093638
    [Google Scholar]
  38. ZhongY. SunQ. HuangH.Y. ZhouY.D. GuanJ.H. MaoF. LinY. XuY.L. [Diagnosis and treatment of occult breast cancer: Report of 23 cases].Zhonghua Zhong Liu Za Zhi201032971671821122392
    [Google Scholar]
  39. KimH. ParkW. KimS.S.S. AhnS.J. KimY.B. KimT.H. KimJ.H. ChoiJ.H. ParkH.J. ChangJ.S. ChoiD.H. Prognosis of patients with axillary lymph node metastases from occult breast cancer: Analysis of multicenter data.Radiat. Oncol. J.202139210711210.3857/roj.2021.0024134619827
    [Google Scholar]
  40. GeL.P. LiuX.Y. XiaoY. GouZ.C. ZhaoS. JiangY.Z. DiG.H. Clinicopathological characteristics and treatment outcomes of occult breast cancer: A SEER population-based study.Cancer Manag. Res.2018104381439110.2147/CMAR.S16901930349371
    [Google Scholar]
  41. SohnG. SonB.H. LeeS.J. KangE.Y. JungS.H. ChoS.H. BaekS. LeeY.R. KimH.J. KoB.S. Yu LeeJ.W. AhnS.H. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: A nationwide retrospective study.J. Surg. Oncol.2014110327027410.1002/jso.2364424863883
    [Google Scholar]
  42. HeM. TangL.C. YuK.D. CaoA.Y. ShenZ.Z. ShaoZ.M. DiG.H. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.Eur. J. Surg. Oncol.201238111022102810.1016/j.ejso.2012.08.02222959166
    [Google Scholar]
  43. HainsworthJD GrecoFA Management of patients with cancer of unknown primary site.Oncology200014563574
    [Google Scholar]
  44. MantieroM. FaggioniG. MenichettiA. FassanM. GuarneriV. ConteP. Gastric linitis plastica and peritoneal carcinomatosis as first manifestations of occult breast carcinoma: A case report and literature review.Case Rep. Oncol. Med.201820181410.1155/2018/471470830073103
    [Google Scholar]
  45. AltundagK. Metastatic occult breast carcinoma to gallbladder initially presenting as acute cholecystitis.J. BUON202126263434077016
    [Google Scholar]
  46. BooijJ. AdamJ.A. van EerdeM.S. BronnerI.M. Paraneoplastic cerebellar syndrome presented as cerebellar hypermetabolism in a patient with occult breast carcinoma.Clin. Nucl. Med.202247213013210.1097/RLU.000000000000401635006107
    [Google Scholar]
  47. CostaR.L.B. Costa-FilhoR.B. RosaM. CzernieckiB.J. Occult breast carcinoma presenting as scalp metastasis.Case Rep. Oncol.201710399299710.1159/00048434629279704
    [Google Scholar]
  48. VadiveluR. DrewS. Phalangeal metastasis secondary to an occult breast carcinoma.Arch. Orthop. Trauma Surg.2002122953053110.1007/s00402‑002‑0399‑212483336
    [Google Scholar]
  49. UppalH.S. AyshfordC.A. WilsonF. Sudden onset bilateral sensorineural hearing loss: A manifestation of occult breast carcinoma.J. Laryngol. Otol.20011151190791010.1258/002221501190932311779308
    [Google Scholar]
/content/journals/cmir/10.2174/1573405620666230515090511
Loading
/content/journals/cmir/10.2174/1573405620666230515090511
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test